David Mack
Oprichter bij PMV PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 30-04-2024
Profiel
David H.
Mack is the founder of PMV Pharmaceuticals, Inc. (founded in 2013) and holds the title of President, Chief Executive Officer & Director.
He is also the founder of EOS Biotechnology, Inc. Dr. Mack's current jobs include being a Director at Intradigm Corp.
since 2006, a Director at Vitra Bioscience, Inc., and a Director at ACMP IV LLC.
His former jobs include being the Chief Executive Officer & Director at Angiosyn, Inc. from 2003 to 2005, a Director at Alta Partners Management Co. LP, a Director at Proacta, Inc., a Director at Ceregene, Inc., an Independent Director at Aerie Pharmaceuticals, Inc. in 2013, a Director at aTyr Pharma, Inc., a Director at Sutro Biopharma, Inc., a Director at Aduro BioTech, Inc. from 2019 to 2020, a Non-Executive Director at Silence Therapeutics Plc from 2010 to 2013, a Director at Pathwork Diagnostics, Inc., a Head-Cancer Biology at Affymetrix, Inc. from 1994 to 1997, and a Member-Polymerase Chain Reaction Invention at Cetus Corp.
Dr. Mack obtained a doctorate degree from The University of Chicago in 1992 and an undergraduate degree from the University of California, Berkeley.
Dr. Mack is also the founder of EOS Biotechnology, Inc...
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2024 | 648 770 ( 1.26% ) | 1 M $ | 30-04-2024 |
Actieve functies van David Mack
| Bedrijven | Functie | Begin |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Oprichter | 01-06-2013 |
| ACMP IV LLC | Directeur/Bestuurslid | - |
Vitra Bioscience, Inc.
 Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | Directeur/Bestuurslid | - |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Directeur/Bestuurslid | 01-05-2006 |
Eerdere bekende functies van David Mack
| Bedrijven | Functie | Einde |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | 05-10-2020 |
| AERIE PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-12-2013 |
| SILENCE THERAPEUTICS PLC | Directeur/Bestuurslid | 26-06-2013 |
Angiosyn, Inc.
 Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Angiosyn, Inc. develops pharmaceutical products for controlling angiogenesis | Algemeen Directeur | 01-01-2005 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Oprichter | 02-01-2003 |
Opleiding van David Mack
| The University of Chicago | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| Bedrijven in privébezit | 13 |
|---|---|
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
Vitra Bioscience, Inc.
Vitra Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Vitra Bioscience, Inc. develops technologies for biological research and drug discovery. Its technology includes cellcard system and cellplex assays which facilitate multiple cell-types and parameters to be evaluated. The cellcard imaging system collects images and then analyzed with proprietary software. The company was founded by Simon Goldbard and is headquartered in Mountain View, CA. | Health Technology |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
| ACMP IV LLC | |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Angiosyn, Inc.
Angiosyn, Inc. Pharmaceuticals: OtherHealth Technology Angiosyn, Inc. develops pharmaceutical products for controlling angiogenesis | Health Technology |
| Cetus Corp. | Health Technology |
